Management 2017-10-02T15:58:20+00:00

David T. Hansen

President/Managing Director

Degree in Economics, Politics and Social Science from Roskilde University, Denmark; MBA from California State University, East Bay, USA, and from IMADEC, Austria. Born 1967. Joined ORIGIO in May 2015 as President & Managing Director. 20 years of global experience in various managerial positions within the Biopharm, ITC and Medtech industries, and within Capital Markets. Following a career at a hedge fund, he was CEO of Copenhagen Bankers and co-founded Mr. Hansen worked for Novo Nordisk, the global leader in diabetes care, from 1995-2008 in General Management, Finance and Business Development roles in Central & East Europe, and as Managing Director, Novo Nordisk Scandinavia AB (2003-2008). In 2008 he joined Taconic Biosciences Inc. as President & Officer, General Manager of the Research Models & Solutions Division.

Jeannett Hvidkjær

Chief Financial Officer, EVP

Bachelor in Business Economics and Accounting from Copenhagen Business School. Born 1966. Joined ORIGIO in 2005 as Chief Accountant. Appointed Chief Financial Officer August 2009. 12 years’ experience as a public accountant at Ernst&Young and 5 years as Chief Account at a national Danish newspaper.

Susanne Hauschildt Bendz

CSO, EVP Innovation and Regulatory

Ph.D. in biology (immunology) from University of Copenhagen. Born 1958. Appointed Executive Vice President August 2004. Previous experience includes Research Assistant, and Clinical Research Director at ALK-Abelló A/S (a leading allergy vaccine company) and later in Coloplast A/S in Wound Care Management Group and Corporate responsible for clinical development (the largest Danish Medical device company).

Marie-Louise Haxthausen

Vice President, Global Marketing

Degree in Business Administration and Strategic Marketing from Copenhagen Business School. Born in Brazil in 1961. Joined ORIGIO a/s January 2015 after 20+ years experience in Sales and Global Marketing. Previously Senior Marketing Director in Pfizer Consumer Health with strong focus on driving global brands and optimizing marketing platforms. Key experience within Life Science and Medical Device products with experience from Ferrosan A/S (Vitamins and Supplements), Coloplast A/S (Wound Care), and Brüel & Kjær (Ultrasound Equipment).

Ulrik Høgh Sørensen

Vice President, Scientific Instruments, Services & Diagnostics

MSc in Chemical Engineering from the Technical University of Denmark with specialization in process/technical chemistry. Born 1971. Joined ORIGIO a/s in October 2015 as Vice President. More than 17 years of experience from process, pharma and biotechnology industries, including 9 years (2006-2015) in an international Life Science Group, Taconic Biosciences, most recently as Vice President of Scientific Operation & Services.

Charles Smith

Vice President, Global Lab Operations

Ph.D. in Biochemistry from the National Institutes of Health and University of Maryland, with specialization in structural virology. Born 1978. Joined Cooper Surgical in 2010. Previously 6  years as Director of ORIGIO Media Operations and Director of Operations for SAGE IVF. Former experience includes Technology Transfer, Science Policy and Career Development roles at The National Institutes of Health in the United States.

Tony Gordon

Vice President of Business Development

Ph.D in molecular biology from Nottingham University and 20 years as Clinical (state registered) Cytogeneticist. Fellow of the Royal Society of Biology. Born 1968. After post-doctoral positions at the Institute of Cancer research and subsequent scientific-commercial positions 2001-2006, followed with positions as Director of PGS at BlueGnome (2006-2012) and Managing Director of Genesis Genetics (2013-2016). Joined Cooper Genomics as Vice President of Business Development as part of the acquisition of Genesis Genetics in 2016.

Lau Diderichsen

Vice President APAC

Degree in Agricultural Science, attended several programs at INSEAD in Europe and Asia. Born 1961. Joined ORIGIO in July 2015 as Acting General Manager of Origio China and later as Vice President APAC.
30 years of international experience in management positions within the Bioscience, Food, Marine and Packaging industries. Previously with Foss A/S in Denmark as Vice President EMEA and APAC.
Spent substantial time in Asia over the past 30 years including stationed in Singapore for 12 years.

Esben Bruun Mortensen

Director, Business Development

Bsc in Biology from KDAS, Degree in Business Strategy Generation and Implementation from London Business School, Program for Executive Development (PED) at IMD Business School. Born 1956. Joined Origio in 2015 as Head of International Business Development WH. Bring along more than 25 years’ experience from International Business Management in the pharmaceutical market and in innovative Start Up companies including 6 years (2007 to 2012) as Director UK/Ire for Novo Nordisk and 2 years (2014 – 2015) as CEO for an early drug discovery company.

Kristofer Karlsson

Vice President EMEA & Commercial Development

M.Sc. in Industrial Engineering and Management Science from Linkoping Technical University in Sweden. Born 1974. Joined ORIGIO in December 2015 as Director, Global Commercial Development. More than 15 years experience in managerial roles within Fast Moving Consumer Products, MedTech and Pharma at Novartis, ALCON and SCA Hygiene Products. Following the start of his career in consumer marketing, Mr. Karlsson joined Novartis eye-care division CIBA VISION in 2005 as Marketing Director. During his 10 years at the company he held roles of increasing responsibility such as Business Unit Managers for two different divisions and General Manager/Managing Director for Alcon Nordic.

Supervisory Board

Paul L. Remmell (Chairman)

President & Chief Executive Officer, CooperSurgical, Inc.

Joined ORIGIO’s board of directors as of August 10, 2012. Mr. Remmell has been Chief Executive Officer of CooperSurgical, The Cooper Companies women’s healthcare business, since January 2012 and he has served as President of CooperSurgical, since December 2004. He previously served as Chief Operating Officer of CooperSurgical from October 2000 to January 2012 and as Vice President of Finance from 1991 to December 2004.

Albert G. White III

Executive Vice President, Chief Financial Officer & Chief Strategy Officer

Joined ORIGIO’s board of directors as Chief Financial Officer in November 2016. He also serves as Executive Vice President and Chief Strategy Officer, positions he has held since December 2015 and July 2011, respectively. Since August 2015, Mr. White also oversees and directs our women’s healthcare business and is currently CEO of Cooper Medical, Inc. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.

Carol R. Kaufmann

Executive Vice President, Secretary & Chief Administrative Officer

Joined ORIGIO’s board of directors as of August 10, 2012. Ms. Kaufman has served as Executive Vice President of The cooper Companies since July 2011. She previously served as Senior Vice President of Legal Affairs from December 2004. She has also served as Vice President and Chief Administrative Officer since October 1995 and as Vice President of Legal Affairs and Secretary since March 1996. From January 1989 through September 1995, she served as Vice President, Secretary and Chief Administrative Officer of Cooper Development Company, a healthcare and consumer products company. She previously held a variety of financial positions with Cooper Laboratories, Inc. (former parent) since joining that company in 1971. Ms. Kaufman currently serves as a director for Chindex, Inc. (NASDAQ: CHDX), a publicly traded provider of health care services in China, and is a member of its audit and compensation committees and chair of the governance and nominating committee of the board of directors.